New Results
Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis
Guillaume Rollin, View ORCID ProfileJosé Lages, View ORCID ProfileTatiana S. Serebriyskaya, View ORCID ProfileDima L. Shepelyansky
doi: https://doi.org/10.1101/614016
Guillaume Rollin
1Institut UTINAM, CNRS, UMR 6213, OSU THETA, Université de Bourgogne Franche-Comté, Besançon, France
José Lages
1Institut UTINAM, CNRS, UMR 6213, OSU THETA, Université de Bourgogne Franche-Comté, Besançon, France
Tatiana S. Serebriyskaya
2Laboratory for Translational Research and Personalized Medicine, Moscow Institute of Physics and Technology, Moscow, Russia
Dima L. Shepelyansky
3Laboratoire de Physique Théorique, IRSAMC, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France
Posted August 26, 2019.
Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis
Guillaume Rollin, José Lages, Tatiana S. Serebriyskaya, Dima L. Shepelyansky
bioRxiv 614016; doi: https://doi.org/10.1101/614016
Subject Area
Subject Areas
- Biochemistry (7789)
- Bioengineering (5674)
- Bioinformatics (21278)
- Biophysics (10575)
- Cancer Biology (8173)
- Cell Biology (11937)
- Clinical Trials (138)
- Developmental Biology (6762)
- Ecology (10401)
- Epidemiology (2065)
- Evolutionary Biology (13863)
- Genetics (9707)
- Genomics (13069)
- Immunology (8139)
- Microbiology (19983)
- Molecular Biology (7842)
- Neuroscience (43052)
- Paleontology (319)
- Pathology (1279)
- Pharmacology and Toxicology (2258)
- Physiology (3351)
- Plant Biology (7232)
- Synthetic Biology (2001)
- Systems Biology (5537)
- Zoology (1128)